Literature DB >> 3212290

Pathogenicity of two strains of Streptococcus uberis infused into lactating and non-lactating bovine mammary glands.

A W Hill1.   

Abstract

Two strains of Streptococcus uberis, one (0140J) resistant to killing by purified bovine polymorphonuclear leucocytes suspended in milk and the other (EF20) readily killed by polymorphonuclear leucocytes were each infused into a mammary quarter of 18 lactating and 10 pregnant non-lactating cows. In the lactating cows 0140J produced clinical disease in 16 of 18 quarters whereas EF20 produced clinical disease in only two of 18 quarters. With the exception of three cows exposed to EF20, the quarters which resisted infection did so without apparent inflammatory reaction. In non-lactating cows both organisms produced clinical disease in six of 10 quarters. Two cows apart, a non-lactating udder was either resistant or sensitive to both organisms.

Entities:  

Mesh:

Year:  1988        PMID: 3212290

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  16 in total

1.  Killing of Streptococcus uberis by bovine neutrophils following growth in chemically defined media.

Authors:  J A Leigh; T R Field
Journal:  Vet Res Commun       Date:  1991       Impact factor: 2.459

2.  Identification and disruption of two discrete loci encoding hyaluronic acid capsule biosynthesis genes hasA, hasB, and hasC in Streptococcus uberis.

Authors:  P N Ward; T R Field; W G Ditcham; E Maguin; J A Leigh
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Bovine mammary epithelial cell invasion by Streptococcus uberis.

Authors:  K R Matthews; R A Almeida; S P Oliver
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

4.  Streptococcus uberis resists the bactericidal action of bovine neutrophils despite the presence of bound immunoglobulin.

Authors:  J A Leigh; T R Field
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

5.  The hyaluronic acid capsule of Streptococcus uberis is not required for the development of infection and clinical mastitis.

Authors:  Terence R Field; Philip N Ward; Lars H Pedersen; James A Leigh
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

6.  Identification of a novel streptococcal gene cassette mediating SOS mutagenesis in Streptococcus uberis.

Authors:  Emilia Varhimo; Kirsi Savijoki; Jari Jalava; Oscar P Kuipers; Pekka Varmanen
Journal:  J Bacteriol       Date:  2007-05-18       Impact factor: 3.490

7.  First insights into the evolution of Streptococcus uberis: a multilocus sequence typing scheme that enables investigation of its population biology.

Authors:  Tracey J Coffey; Gillian D Pullinger; Rachel Urwin; Keith A Jolley; Stephen M Wilson; Martin C Maiden; James A Leigh
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

8.  Greater expression of TLR2, TLR4, and IL6 due to negative energy balance is associated with lower expression of HLA-DRA and HLA-A in bovine blood neutrophils after intramammary mastitis challenge with Streptococcus uberis.

Authors:  Kasey M Moyes; James K Drackley; Dawn E Morin; Juan J Loor
Journal:  Funct Integr Genomics       Date:  2010-03       Impact factor: 3.410

9.  Local vaccination with killed Streptococcus uberis protects the bovine mammary gland against experimental intramammary challenge with the homologous strain.

Authors:  J M Finch; A W Hill; T R Field; J A Leigh
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

10.  Gene network and pathway analysis of bovine mammary tissue challenged with Streptococcus uberis reveals induction of cell proliferation and inhibition of PPARgamma signaling as potential mechanism for the negative relationships between immune response and lipid metabolism.

Authors:  Kasey M Moyes; James K Drackley; Dawn E Morin; Massimo Bionaz; Sandra L Rodriguez-Zas; Robin E Everts; Harris A Lewin; Juan J Loor
Journal:  BMC Genomics       Date:  2009-11-19       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.